Securities Code: 002432 Securities Abbreviation: Jiuyuan Medical Announcement No.: 2026-017 Tianjin Health Medical Electronic Co., Ltd. Special Report on the Fund Raising, Management, and Use of Raised Funds in 2025 The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and contains no false records, misleading statements, or material omissions.
I. Basic Situation of Raised Funds Tianjin Health Medical Electronic Co., Ltd. (hereinafter referred to as the "Company") was approved by the China Securities Regulatory Commission (hereinafter referred to as the "CSRC") in its "Approval on Approving the Non-public Offering of Shares by Tianjin Health Medical Electronic Co., Ltd." (Zhengjian Permit [2020] No. 3324) to issue 45,797,101 shares of RMB common stock (A shares) in a non-public offering in 2020. The par value per share is RMB 1.00, and the offering price per share is RMB 6.90. The total amount of raised funds is RMB 315,999,996.90. After deducting the expenses related to the offering of RMB 6,630,702.76, the net amount of raised funds is RMB 309,369,294.14. The arrival of the aforementioned raised funds was verified by Dahua Certified Public Accountants (Special General Partnership), who issued the "Capital Verification Report on the Non-public Offering of RMB Common Stock (A Shares) by Tianjin Health Medical Electronic Co., Ltd." (Dahua Verification Letter [2021] No. 000141).
As of December 31, 2025, the Company's use and balance of raised funds are as follows: